Buprenorphine transdermal skin patch and Dolutegravir and lamivudine
Determining the interaction of Buprenorphine transdermal skin patch and Dolutegravir and lamivudine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: dolutegravir / lamivudine
Brand name: Dovato
Synonyms: Dolutegravir and Lamivudine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Dolutegravir and rilpivirine
- Buprenorphine transdermal skin patch-Dolutegravir Sodium
- Buprenorphine transdermal skin patch-Dolutegravir Sodium And Lamivudine
- Buprenorphine transdermal skin patch-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Buprenorphine transdermal skin patch-Dom-Etoposide
- Buprenorphine transdermal skin patch-Donatuss DC Syrup
- Dolutegravir and lamivudine-Buprenorphine, Buprenorphine Hydrochloride
- Dolutegravir and lamivudine-Buprenorphine/naloxone Oromucosal, Sublingual
- Dolutegravir and lamivudine-Buproban
- Dolutegravir and lamivudine-Bupropion
- Dolutegravir and lamivudine-Bupropion and naltrexone
- Dolutegravir and lamivudine-Bupropion Extended-Release Tablets